PubRank

Jenefer M Blackwell

Author PubWeight™ 123.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011 13.23
2 The genome of the kinetoplastid parasite, Leishmania major. Science 2005 8.64
3 A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010 8.48
4 Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 2013 7.44
5 Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011 5.56
6 Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 2009 4.61
7 Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 2010 4.42
8 BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002 3.75
9 Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 2012 3.40
10 Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? Lancet Infect Dis 2006 1.56
11 Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet 2012 1.52
12 IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J Immunol 2005 1.48
13 Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis 2002 1.42
14 IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 2006 1.38
15 P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma gondii, by human and murine macrophages. J Immunol 2010 1.33
16 Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One 2008 1.32
17 Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 2013 1.15
18 Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function. Infect Immun 2007 1.11
19 Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan. J Infect Dis 2007 1.09
20 Geographic information systems and applied spatial statistics are efficient tools to study Hansen's disease (leprosy) and to determine areas of greater risk of disease. Am J Trop Med Hyg 2010 1.07
21 Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet 2005 1.06
22 Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan. PLoS Genet 2007 1.06
23 From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection. Vaccine 2005 1.02
24 Genome-wide association study to identify the genetic determinants of otitis media susceptibility in childhood. PLoS One 2012 1.02
25 TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia). PLoS Negl Trop Dis 2011 1.00
26 CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study. BMC Med Genet 2010 0.99
27 HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood 2007 0.99
28 Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United Kingdom. Infect Immun 2004 0.99
29 Slc11a1-mediated resistance to Salmonella enterica serovar Typhimurium and Leishmania donovani infections does not require functional inducible nitric oxide synthase or phagocyte oxidase activity. J Leukoc Biol 2004 0.98
30 Unraveling the genetics of otitis media: from mouse to human and back again. Mamm Genome 2010 0.98
31 Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection. Infect Immun 2005 0.97
32 Genetic admixture in Brazilians exposed to infection with Leishmania chagasi. Ann Hum Genet 2009 0.96
33 The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol 2010 0.95
34 Host genetic and epigenetic factors in toxoplasmosis. Mem Inst Oswaldo Cruz 2009 0.95
35 Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. Mol Biochem Parasitol 2004 0.94
36 Wound healing genes and susceptibility to cutaneous leishmaniasis in Brazil. Infect Genet Evol 2012 0.94
37 Polymorphism in NOD2, Crohn's disease, and susceptibility to pulmonary tuberculosis. FEMS Immunol Med Microbiol 2004 0.93
38 Genetic susceptibility to otitis media in childhood. Laryngoscope 2012 0.93
39 Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz 2009 0.93
40 Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis. J Infect Dis 2012 0.93
41 Evolution of differences in transport function in Slc11a family members. J Biol Chem 2007 0.92
42 DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice. Infect Immun 2004 0.92
43 Sudanese mucosal leishmaniasis: isolation of a parasite within the Leishmania donovani complex that differs genotypically from L. donovani causing classical visceral leishmaniasis. Infect Genet Evol 2005 0.92
44 Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. Biochem J 2002 0.92
45 From genomes to vaccines: Leishmania as a model. Philos Trans R Soc Lond B Biol Sci 2002 0.92
46 Polymorphism in IL1B: IL1B-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1beta in IFN-gamma primed ex-vivo whole blood assay. J Endotoxin Res 2005 0.91
47 Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis. PLoS Negl Trop Dis 2012 0.90
48 Genetic and functional evaluation of the role of DLL1 in susceptibility to visceral leishmaniasis in India. Infect Genet Evol 2012 0.88
49 Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice. Infect Immun 2006 0.88
50 Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India. BMC Med Genet 2011 0.87
51 A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol Psychiatry 2013 0.87
52 No evidence for association between SLC11A1 and visceral leishmaniasis in India. BMC Med Genet 2011 0.86
53 Genetic and functional evidence implicating DLL1 as the gene that influences susceptibility to visceral leishmaniasis at chromosome 6q27. J Infect Dis 2011 0.85
54 Influence of Slc11a1 (formerly Nramp1) on DSS-induced colitis in mice. J Leukoc Biol 2008 0.84
55 Classification and regression tree and spatial analyses reveal geographic heterogeneity in genome wide linkage study of Indian visceral leishmaniasis. PLoS One 2010 0.84
56 A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis. Vaccine 2008 0.84
57 Incomplete glycosylation and defective intracellular targeting of mutant solute carrier family 11 member 1 (Slc11a1). Biochem J 2004 0.84
58 A genome-wide search for type 2 diabetes susceptibility genes in an extended Arab family. Ann Hum Genet 2013 0.84
59 Cytokine responses to novel antigens in a peri-urban population in Brazil exposed to Leishmania infantum chagasi. Am J Trop Med Hyg 2012 0.83
60 Candidate gene association study of solute carrier family 11a members 1 (SLC11A1) and 2 (SLC11A2) genes in Alzheimer's disease. Neurosci Lett 2005 0.81
61 Genetic and functional evidence for a role for SLC11A1 in susceptibility to otitis media in early childhood in a Western Australian population. Infect Genet Evol 2013 0.78
62 Genetic research and aboriginal and Torres Strait Islander Australians. J Bioeth Inq 2012 0.77
63 Selection of appropriate serological tests to measure the incidence of natural Leishmania infantum infection during DNA/MVA prime/boost canine vaccine trials. Vet Parasitol 2009 0.77
64 Comparative analysis of two slc11 (Nramp) loci in Takifugu rubripes. DNA Cell Biol 2004 0.76
65 Genetic and functional evidence for a locus controlling otitis media at chromosome 10q26.3. BMC Med Genet 2014 0.75
66 Postgenomic research on leishmaniasis: a critical self-appraisal. Trends Parasitol 2008 0.75